Mitesh

As part of our Funding & Reimbursement Shorts  series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on the paper prescription sorting and submission process. For the end-of-month submission, pharmacy teams are required to sort the month’s paper dispensing activity. For the paper prescription sorting and submission process, pharmacy teams [...]

The post Funding & Reimbursement Shorts: Paper prescription sorting and submission process appeared first on Community Pharmacy England.

From 1 September 2025,  Dydrogesterone 10mg tablets (Nalvee®) has been added to the list of medicines covered by the HRT prepayment certificate (HRT PPC). This change has been reflected in Part XVI of the September 2025 Drug Tariff and on the NHSBSA’s website. Community Pharmacy England has also updated its HRT medicines list to reflect the [...]

The post Dydrogesterone 10mg tablets (Nalvee®) added to the HRT PPC medicines list appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the June and July 2025 reimbursement prices for the following products, to reflect an increase in their NHS list prices. To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed [...]

The post Retrospective reimbursement prices for June and July 2025 appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the June and July 2025 reimbursement prices for the following products, to reflect an increase in their NHS list prices. To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed [...]

The post Retrospective reimbursement prices for June and July 2025 appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Levetiracetam 100mg/ml oral solution (Accord Healthcare Limited) Date issued: 14 August 2025 Drug Alert Number: EL(25)A/40 Accord Healthcare Limited, UK has informed the MHRA that the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SPC) do not contain all the required safety information. DMRC reference number: DMRC-35838218 Marketing Authorisation [...]

The post MHRA Class 4 Medicines Defect Notification: Levetiracetam 100mg/ml oral solution (Accord Healthcare Limited) appeared first on Community Pharmacy England.